Orchid Pharma Limited (ORCHPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs115.10 Million ≈ $1.24 Million USD) by net assets (Rs12.74 Billion ≈ $137.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Orchid Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Orchid Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Orchid Pharma Limited total liabilities for a breakdown of total debt and financial obligations.

Orchid Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orchid Pharma Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
FocalTech Systems Co Ltd
TW:3545
0.063x
Sumber Global Energy Tbk Pt
JK:SGER
0.029x
Standard Chemical & Pharmaceutical Co Ltd
TW:1720
0.057x
NICE Holdings Co. Ltd
KO:034310
0.130x
Mo-Bruk SA
WAR:MBR
-0.056x
FPT Securities JSC
VN:FTS
0.382x
Huasi Agricultural Development Co Ltd
SHE:002494
-0.003x
Nordic Paper Holding AB
ST:NPAPER
0.115x

Annual Cash Flow Conversion Efficiency for Orchid Pharma Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Orchid Pharma Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see ORCHPHARMA stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs12.67 Billion
≈ $137.05 Million
Rs192.15 Million
≈ $2.08 Million
0.015x -85.93%
2024-03-31 Rs11.69 Billion
≈ $126.47 Million
Rs1.26 Billion
≈ $13.63 Million
0.108x +304.58%
2023-03-31 Rs6.89 Billion
≈ $74.47 Million
Rs183.38 Million
≈ $1.98 Million
0.027x -81.36%
2022-03-31 Rs6.47 Billion
≈ $70.01 Million
Rs924.75 Million
≈ $10.00 Million
0.143x +295.42%
2021-03-31 Rs6.53 Billion
≈ $70.61 Million
Rs235.86 Million
≈ $2.55 Million
0.036x -65.76%
2020-03-31 Rs7.66 Billion
≈ $82.84 Million
Rs808.03 Million
≈ $8.74 Million
0.105x +717.65%
2019-03-31 Rs-7.04 Billion
≈ $-76.14 Million
Rs120.24 Million
≈ $1.30 Million
-0.017x -47.30%
2018-03-31 Rs-7.92 Billion
≈ $-85.63 Million
Rs91.81 Million
≈ $992.84K
-0.012x +98.65%
2017-03-31 Rs-4.67 Billion
≈ $-50.48 Million
Rs4.01 Billion
≈ $43.36 Million
-0.859x -119.85%
2016-03-31 Rs490.45 Million
≈ $5.30 Million
Rs2.12 Billion
≈ $22.95 Million
4.327x +679.20%
2015-03-31 Rs3.29 Billion
≈ $35.62 Million
Rs-2.46 Billion
≈ $-26.61 Million
-0.747x -353.59%
2013-03-31 Rs3.81 Billion
≈ $41.16 Million
Rs1.12 Billion
≈ $12.12 Million
0.295x -52.70%
2012-03-31 Rs11.83 Billion
≈ $127.98 Million
Rs7.37 Billion
≈ $79.71 Million
0.623x +100.87%
2011-03-31 Rs10.71 Billion
≈ $115.84 Million
Rs3.32 Billion
≈ $35.92 Million
0.310x +947.20%
2010-03-31 Rs9.38 Billion
≈ $101.40 Million
Rs-343.17 Million
≈ $-3.71 Million
-0.037x -150.53%
2009-03-31 Rs6.34 Billion
≈ $68.54 Million
Rs459.01 Million
≈ $4.96 Million
0.072x -77.10%
2008-03-31 Rs6.65 Billion
≈ $71.92 Million
Rs2.10 Billion
≈ $22.74 Million
0.316x +63.88%
2007-03-31 Rs4.85 Billion
≈ $52.46 Million
Rs936.11 Million
≈ $10.12 Million
0.193x +1627.98%
2006-03-31 Rs7.76 Billion
≈ $83.88 Million
Rs-97.95 Million
≈ $-1.06 Million
-0.013x -106.68%
2005-03-31 Rs4.61 Billion
≈ $49.83 Million
Rs870.92 Million
≈ $9.42 Million
0.189x +667.99%
2004-03-31 Rs4.10 Billion
≈ $44.38 Million
Rs-136.54 Million
≈ $-1.48 Million
-0.033x --

About Orchid Pharma Limited

NSE:ORCHPHARMA India Drug Manufacturers - Specialty & Generic
Market Cap
$343.23 Million
Rs31.74 Billion INR
Market Cap Rank
#14400 Global
#693 in India
Share Price
Rs625.75
Change (1 day)
+2.10%
52-Week Range
Rs482.45 - Rs871.95
All Time High
Rs2527.90
About

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, m… Read more